Pancreatic islet transplantation for treating diabetes

Bibliography

• BOYLE JP, HONEYCUTT AA, NARAYAN KM et al.: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care (2001) 24:1936-1940.
   PubMed Web of Science ®Google Scholar
• DCCT RES GROUP: Diabetes control and complications trial (DCCT) Update. Diabetes Care (1990) 13:427-433.
   PubMed Web of Science ®Google Scholar
• DCCT RES GROUP: Adverse events and their association with treatment regimens in the diabetes control and complications trial. Diabetes Care (1995) 18:1415-1427.
   PubMed Web of Science ®Google Scholar
• VENSTROM JM, MCBRIDE MA, ROTHER KI, HIRSHBERG B, ORCHARD TJ, HARLAN DM: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA (2003) 290:2817-2823.
   PubMed Web of Science ®Google Scholar
• NAJARIAN JS, SUTHERLAND DE, MATAS AJ et al.: Human islet transplantation: A preliminary report. Transplant. Proc. (1977) 9:233-236.
   PubMed Web of Science ®Google Scholar
• HERING B, RICORDI C: Islet transplantation for patients with Type 1 diabetes: results, research priorities, and reasons for optimism. Graft (1999) 2:12-27.
   Google Scholar
• RICORDI C, STROM TB: Clinical islet transplantation: advances and immunological challenges. Nat. Rev. Immuunol. (2004) 4:259-268.
   PubMed Web of Science ®Google Scholar
• SHAPIRO AM, LAKEY JR, RYAN EA et al.: Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. (2000) 343:230-238.
   PubMed Web of Science ®Google Scholar
• ROTHER KI, HARLAN DM: Challenges facing islet transplantation for the treatment of Type 1 diabetes mellitus. J. Clin. Invest. (2004) 114:877-883.
   PubMed Web of Science ®Google Scholar
• BAIDAL DA, FROUD T, FERREIRA JV, KHAN A, ALEJANDRO R, RICORDI C: The bag method for islet cell infusion. Cell Transplant. (2003) 12:809-813.
   PubMed Web of Science ®Google Scholar
• FROUD T, YRIZARRY JM, ALEJANDRO A, RICORDI C: Use of D-StatTM to prevent bleeding following percutaneous transhepatic intraportal islet transplantation. Cell Transplant. (2004) 13:55-59.
   PubMed Web of Science ®Google Scholar
• SHAPIRO AM, RICORDI C, HERING B: Edmonton’s islet success has indeed been replicated in elsewhere. Lancet (2003) 362:1212.
   Google Scholar
• AULT A: Edmonton’s islet success tough to duplicate elsewhere. Lancet (2003) 361:2054.
   PubMedGoogle Scholar
• SHAPIRO AM, LAKEY JR, PATY BW et al.: Strategic opportunities in clinical islet transplantation. Transplantation (2005) 79:1304-1307.
   PubMed Web of Science ®Google Scholar
• RYAN EA, PATY BW, SENIOR PA et al.: Five-year follow-up after clinical islet transplantation. Diabetes (2005) 54:2060-2069.
   PubMed Web of Science ®Google Scholar
• COUZIN J: Diabetes. Islet transplants face test of time. Science (2004) 306:34-37.
   PubMed Web of Science ®Google Scholar
• ROBERTSON RP: Islet transplantation: travels up the learning curve. Curr. Diab. Res. (2002) 2:365-370.
   PubMedGoogle Scholar
• POGGIOLI R, PONTE G, BAIDAL DA et al.: Quality of life after islet transplantation. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-099.
   Google Scholar
• BARSHES NR, VANATTA JC, BRUNICARDI F, UDELL IW, BALKRISHNAN R, GOSS JA: Health-related quality of life after pancreatic islet transplantation: a longitudinal study. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-145.
   Google Scholar
• KAUFMAN DB, BAKER MS, CHEN X, LEVENTHAL JR, STUART FP: Sequential kidney/islet transplantation using prednisone-free immunosuppression. Am. J. Transplant. (2002) 2:674-677.
   PubMed Web of Science ®Google Scholar
• FROUD T, BAIDAL DA, CURE P et al.: Islet after kidney transplantation, Miami experience. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-047.
   Google Scholar
• TOSO C, BAERTSCHIGER R, MOREL P et al.: Insulin independence in recipients of islet after kidney allogeneic transplantation using a steroid-free protocol. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-046.
   Google Scholar
• DENG S, VELIDEDEOGLU E, FRANK A et al.: Comparison of the early outcome of islet alone transplants. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-043.
   Google Scholar
• ANDRES A, TOSO C, MOREL P et al.: Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation. Transplant. Proc. (2005) 37:1326-1327.
   PubMed Web of Science ®Google Scholar
• MARKMANN JF, DENG S, DESAI NM et al.: The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation (2003) 75:1423-1429.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, TANAKA K: Pancreatic islet cell transplantation using non-heart-beating-donors (NHBDs). J. Hepato-Biliary-Pancreatic Surg. (2005) 12:227-230.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, TANAKA K, STRONG DM, REEMS JA: Efficacy of human islet isolation from the tail section of pancreas for the possibility of living donor islet transplantation. Transplantation (2004) 78:839-843.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, OKITSU T, IWANAGA Y et al.: Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method. Transplantation (2006) (In Press).
   Google Scholar
• OKITSU T, MATSUMOTO S, IWANAGA Y et al.: Kyoto islet isolation method- The optimized one for non-heart-beating donors with highly efficient islet retrieval. Transplant. Proc. (2005) 37(8):3391-3392.
   PubMed Web of Science ®Google Scholar
• NAGATA H, MATSUMOTO S, IWANAGA Y et al.: Procurement of the human pancreas for pancreatic islet transplantation from marginal cadaver donors. Transplantation (2006) (In Press).
   Google Scholar
• CORLETT MP, SHARP DW: The effect of pancreatic warm ischemia on islet isolation in rats and dogs. J. Surg. Res. (1988) 45:531-536.
   PubMed Web of Science ®Google Scholar
• SAWADA T, MATSUMOTO I, NAKANO M, KIRCHHOF N, SUTHERLAND DE, HERING BJ: Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation (2003) 75:1965-1969.
   PubMed Web of Science ®Google Scholar
• BANDO T, KOSAKA S, LIU C et al.: Effects of newly developed solutions containing trehalose on twenty-hour canine lung preservation. J. Thorac. Cardiovasc. Surg. (1994) 108:92-98.
   PubMed Web of Science ®Google Scholar
• LIU CJ, BANDO T, HIRAI T et al.: Improved 20-hour canine lung preservation with a new solution-ET-Kyoto solution. Eur. J. Cardiothorac. Surg. (1995) 9:548-552.
   PubMed Web of Science ®Google Scholar
• CONTRACTOR HH, JOHNSON PR, CHADWICK DR, ROBERTSON GS, LONDON NJ: The effect of UW solution and its components on the collagenase digestion of human and porcine pancreas. Cell Transplant. (1995) 4:615-619.
   PubMed Web of Science ®Google Scholar
• KAWAMURA T, KURODA Y, SUZUKI Y et al. Seventy-two-hour preservation of the canine pancreas by the two-layer (Euro-Collins’ solution/perfluorochemical) cold storage method. Transplantation (1989) 47:776-778.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, KURODA Y: Perfluorocarbon for organ preservation before transplantation. Transplantation (2002) 74:1804-1809.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S: Clinical application of perfluorocarbons for organ preservation. Artif. Cells Blood Substit. Immobil. Biotechnol. (2005) 33:75-82.
   PubMed Web of Science ®Google Scholar
• RIDGWAY DM, SWIFT SM, WHITE A et al.: Improvement of islet yield by pancreas preservation using trehalose containing solution. Acta Diabetol. (2003) 40:37.
   PubMedGoogle Scholar
• BRANDHORST D, IKEN M, BRENDEL MD, BRETZEL RG, BRANDHORST H: Successful pancreas preservation by a perfluorocarbon-based one-layer method for subsequent pig islet isolation. Transplantation (2005) 79:443-437.
   Google Scholar
• MATSUMOTO S, RIGLEY T, QUALLEY S et al.: Efficacy of the oxygen-charged static two-layer method for short-term pancreas preservation and islet isolation from nonhuman primate and human pancreata. Cell Transplant. (2002) 11:769-777.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, RIGLEY T, REEMS J et al.: Improved islet yields from macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am. J. Transplant. (2003) 3:53-63.
   PubMed Web of Science ®Google Scholar
• LAKEY JR, HELMS LM, KIN T et al.: Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation (2001) 72:565-570.
   PubMed Web of Science ®Google Scholar
• ROSE NL, PALCIC MM, HELMS LM, LAKEY JR: Evaluation of Pefabloc as a serine protease inhibitor during human-islet isolation. Transplantation (2003) 75:462-466.
   PubMed Web of Science ®Google Scholar
• ROSE NL, PALCIC MM, SHAPIRO AM, LAKEY JR: Endogenous pancreatic enzyme activity levels show no significant effect on human islet isolation yield. Cell Transplant. (2004) 13:153-160.
   PubMed Web of Science ®Google Scholar
• HEISER A, ULRICHS K, MULLER-RUCHHOLTZ W. Isolation of porcine pancreatic islets: low trypsin activity during the isolation procedure guarantees reproducible high islet yields. J. Clin. Lab. Anal. (1994) 8:407-411.
   PubMed Web of Science ®Google Scholar
• BASIR I, VAN DER BURG MP, SCHERINGA M, TONS A, BOUWMAN E: Improved outcome of pig islet isolation by Pefabloc inhibition of trypsin. Transplant. Proc. (1997) 29:1939-1941.
   PubMed Web of Science ®Google Scholar
• ROBERTSON GS, CHADWICK DR, DAVIES J et al.: The effectiveness of components of University of Wisconsin solution in improving human pancreatic islet purification. Transplantation (1994) 57:346-354.
   PubMed Web of Science ®Google Scholar
• VAN DER BURG MP, BASIR I, BOUWMAN E: No porcine islet loss during density gradient purification in a novel iodixanol in University of Wisconsin solution. Transplant. Proc. (1998) 30:362-363.
   PubMed Web of Science ®Google Scholar
• VAN DER BURG MP, GRAHAM JM: Iodixanol density gradient preparation in University of Wisconsin solution for porcine islet purification. Sci. World J. (2003) 3:1154-1159.
   Google Scholar
• HERING BJ, KANDASWAMY R, HARMON JV et al.: Transplantation of cultured islets from two-layer preserved pancreases in Type 1 diabetes with anti-CD3 antibody. Am. J. Transplant. (2004) 4:390-401.
   PubMed Web of Science ®Google Scholar
• HERING BJ, KANDASWAMY RR, ANSITE JD et al.: Single-donor, marginal-dose islet transplantation in patients with Type 1 diabetes. JAMA (2005) 293:830-835.
   PubMed Web of Science ®Google Scholar
• HERING BJ: Achieving and maintaining insulin independent in human islet transplant recipients. Transplantation (2005) 79:1296-1297.
   PubMed Web of Science ®Google Scholar
• LAKEY JR, WARNOCK GL, RAJOTTE RV et al.: Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation (1996) 61:1047-1053.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, YAMADA Y, OKITSU T et al.: Simple evaluation of engraftment by secretory unit of islet transplant object (SUITO) for living donor and cadaveric donor fresh or cultured islet transplantation. Transplant. Proc. (2005) 37(8):3435-3437.
   PubMed Web of Science ®Google Scholar
• FRANK A, DENG S, HUANG X et al.: Transplantation for Type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets. Ann. Surg. (2004) 240:631-640.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, OKITSU T, IWANAGA Y et al.: Insulin independence after living donor distal pancreatectomy and islet allotransplantation. Lancet (2005) 365:1642-1644.
   PubMed Web of Science ®Google Scholar
• TAKADA M, NADEAU K, HANCOCK W et al.: Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation (1998) 65:1533-1542.
   PubMed Web of Science ®Google Scholar
• CONTRERAS JL, ECKSTEIN C, SMYTH CA et al.: Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes (2003) 52:2935-2942.
   PubMed Web of Science ®Google Scholar
• GRUESSNER RW, SUTHERLAND DE: Living donor pancreas transplantation. Transplant Rev. (2002) 16:108-119.
   Google Scholar
• AMIEL SA, RELA M: Live organ-donation for islet transplantation. Lancet (2005) 365:1603-1604.
   PubMed Web of Science ®Google Scholar
• SLINGSBY BT, AKABAYASHI A: Live organ-donation for islet transplantation. Lancet (2005) 366:26-27.
   PubMedGoogle Scholar
• RICORDI C, INVERARDI L, KENYON NS, GOSS J, BERTUZZI F, ALEJANDRO R: Requirements for success in clinical islet transplantation. Transplantation (2005) 79:1298-1300.
   PubMed Web of Science ®Google Scholar
• RICORDI C, LACY PE, LINKE EH, OLACK BJ, SHARP DW: Automated method for islet isolation of human pancreatic islets. Diabetes (1988) 37:413-420.
   PubMed Web of Science ®Google Scholar
• BENHAMOU, PY, WATT PC, MULLEN Y et al.: Human islet isolation in 104 consecutive cases. Factors affecting isolation success. Transplantation (1994) 57:1804-1810.
   PubMed Web of Science ®Google Scholar
• BRANDHORST D, HERING BJ, BRANDHORST H, FEDERLIN K, BRETZEL RG: Influence of donor data and organ procurement on human islet isolation. Transplant. Proc. (1994) 26:592-593.
   PubMed Web of Science ®Google Scholar
• KETCHUM RJ, NICOLAE M, JAHR H et al.: Analysis of donor age and cold ischemic time as factors in cadaveric human islet isolation. Transplant. Proc. (1994) 26:596-597.
   PubMed Web of Science ®Google Scholar
• UNE S, ATIYA S, OHTUKA S et al.: Re-evaluation of donor factors affecting islet isolation from human pancreas using two-step digestion method. Transplant. Proc. (1997) 29:1969.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, ZHANG G, QUALLEY S et al.: A. Analysis of donor factors affecting human islet isolation with current isolation protocol. Transplant. Proc. (2004) 36:1034-1036.
   PubMed Web of Science ®Google Scholar
• TSUJINO T, KOMATSU Y, ISAYAMA H et al.: Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled tiral. Clin. Gastroenterol. Hepatol. (2005) 3:376-383.
   PubMed Web of Science ®Google Scholar
• ALIVA JG, TSUJIMURA T, OBERHOLZER J et al.: Improvement of pancreatic islet isolation outcomes using glutamine perfusion during isolation procedure. Cell Transplant. (2003) 12:877-881.
   PubMed Web of Science ®Google Scholar
• AVILA JG, BARBARO B, ANTONIO G et al.: Intraductal glutamine administration reduces oxidative injury during human pancreatic islet isolation. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) PS-002.
   Google Scholar
• CLARK LC, GOLLAN F: Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science (1966) 152:1755-1756.
   Google Scholar
• MATSUMOTO S, KANDASWAMY R, SUTHERLAND DE et al.: Clinical application of the two-layer [University of Wisconsin solution (UW)/perfluorochemical (PFC) plus O2] method of pancreas preservation before transplantation. Transplantation (2000) 70:771-774.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, KURODA Y, HAMANO M et al.: Direct evidence of pancreatic tissue oxygenation during preservation by the two-layer method. Transplantation (1996) 62:1667-1670.
   PubMed Web of Science ®Google Scholar
• TANIOKA Y, KURODA Y, KIM Y et al.: The effect of ouabain (inhibitor of an ATP-dependent Na+/K+ pump) on the pancreas graft during preservation by the two-layer method. Transplantation (1996) 62:1730-1734.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, FUJINO Y, SUZUKI Y et al.: Evidence of protein synthesis during resuscitation of ischemically damaged canine pancreas by the two-layer method. Pancreas (2000) 20:411-414.
   PubMed Web of Science ®Google Scholar
• KURODA Y, FUJITA H, MATSUMOTO S et al.: Protection of canine pancreatic microvascular endothelium against cold ischemic injury during preservation by the two-layer method. Transplantation (1997) 64:948-953.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, KURODA Y, SUZUKI Y, KU Y, FUJITA H, SAITOH Y: Thromboxane A2 synthesis inhibitor OKY046 ameliorates vascular endothelial injury of pancreas graft during preservation by the two-layer UW solution/perfluorochemical method at 20 degrees C. Transplant. Proc. (1997) 29:1359-1362.
   PubMed Web of Science ®Google Scholar
• PAPAS KK, HERING BJ, GUNTHER L, PAPPEL MJ, COLTON CK, AVGOUSTINIATOS ES: Pancreas oxygenation is inadequate during preservation with the two layer method. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-130.
   Google Scholar
• LAKEY JR, WARNOCK GL, SHAPIRO AM et al.: Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. (1999) 8:285-292.
   PubMed Web of Science ®Google Scholar
• LINETSKY E, BOTTINO R, LEHMANN R, ALEJANDRO R, INVERARDI L, RICORDI C: Improved human islet isolation using a new enzyme blend, Liberase. Diabetes (1997) 46:1120-1123.
   PubMed Web of Science ®Google Scholar
• OLACK BJ, SWANSON CJ, HOWARD TK, MOHANAKUMAR T: Improved method for the isolation and purification of human islets of Langerhans using Liberase enzyme blend. Hum. Immunol. (1999) 60:1303-1309.
   PubMed Web of Science ®Google Scholar
• BARNETT MJ, ZHAI XW, LEGATT DF, CHENG SB, SHAPIRO AM, LAKEY JR: Quantitative assessment of collagenase blends for human islet isolation. Transplantation (2005) 80:723-728.
   PubMed Web of Science ®Google Scholar
• BUCHER P, MATHE Z, MOREL P et al.: Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation (2005) 79:91-97.
   PubMed Web of Science ®Google Scholar
• BRANDHORST H, BRANDHORST D, HESSE F et al.: Successful human islet isolation utilizing recombinant collagenase. Diabetes (2003) 52:91-97.
   Google Scholar
• HERING BJ, MUENCH KP, SCHELZ J et al.: The evaluation of neutral density separation utilizing Ficoll-sodium diatrizoate and Nycodenz and centrifugal elutriation in the purification of bovine and canine islet preparations. Horm. Metab. Res. Suppl. (1990) 25:57-63.
   PubMedGoogle Scholar
• LAKE SP, BASSETT PD, LARKINS A et al.: Large-sale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes (1989) 38(Suppl. 1):143-145.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO S, ZHANG HJ, GILMORE T et al.: Large-scale isopycnic islet purification utilizing non-toxic, endotoixn-free media facilitates immediate single-donor pig islet allograft function. Transplantation (1998) 66(Suppl.):30.
   Google Scholar
• MATSUMOTO S, SHIBATA S, KIRCHHOF N et al.: Immediate reversal of diabetes in primates following intraportal transplantation of porcine islets purified on a new histidine – lactobionate – iodixanol gradient. Transplantation (1999) 67:S220.
   Web of Science ®Google Scholar
• RYAN E, LAKEY J, RAJOTTE R et al.: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes (2001) 50:710-719.
   PubMed Web of Science ®Google Scholar
• RYAN E, LAKEY J, PATY B et al.: Successful islet transplantation: continued insulin reserve provide long-term glycemic control. Diabetes (2002) 51:2148-2157.
   PubMed Web of Science ®Google Scholar
• HERING BJ, WIJKSTROM M, ECKMAN PM: Islet transplantation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds), Springer-Verlag, New York, USA (2004):583-626.
   Google Scholar
• KORSGREN O, NILSSON B, BERNE C et al.: Current status of clinical islet transplantation. Transplantation (2005) 79:1289-1293.
   PubMed Web of Science ®Google Scholar
• BENNET W, SUNDBERG B, GROTH C et al.: Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 48:1907-1914.
   PubMed Web of Science ®Google Scholar
• MOBERG L, JOHANSSON H, LUKINIUS A et al.: Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet (2002) 360:2039-2045.
   PubMed Web of Science ®Google Scholar
• TITUS TT, HORTON PJ, BADET L et al.: Adverse outcome of human islet-allogenic blood interaction. Transplantation (2003) 75:1317-1322.
   PubMed Web of Science ®Google Scholar
• GOTO M, JOHANSSON H, MAEDA A, ELGUE G, KORSGREN O, NILSSON B: Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation (2004) 77:741-747.
   PubMed Web of Science ®Google Scholar
• CONTRERAS JL, ECKSTEIN C, SMYTH CA: Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes (2004) 53:2804-2814.
   PubMed Web of Science ®Google Scholar
• OZMEN L, EKDAHL KN, ELGUE G, LARSSON R, KORSGREN O, NILSSON B: Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets. Diabetes (2002) 51:1779-1784.
   PubMed Web of Science ®Google Scholar
• AKIMA S, HAWTHRONE WJ, FAVALORO EJ et al.: Tirofiban and activated protein C synergistically inhibit the instant blood mediated inflammatory reaction from islet cells exposure to blood. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-093.
   Google Scholar
• FARNEY AC, XENOS E, SUTHERLAND DE et al.: Inhibition of pancreatic beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. Transplant. Proc. (1993) 25:865-866.
   PubMed Web of Science ®Google Scholar
• NASH JR, EVERSON NW, WOOD RF, BELL PR: Effect of silica and carrageenan on the survival of islet allografts. Transplantation (1980) 29:206-208.
   PubMed Web of Science ®Google Scholar
• NOMIKOS IN, PROWSE SJ, CAROTENUTO P, LAFFERTY KJ: Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes (1986) 35:1302-1304.
   PubMed Web of Science ®Google Scholar
• SHIBATA S, MATSUMOTO S, SAGESHIMA J et al.: Temporary treatment with sirolimus and low-trough cyclosporine prevents acute islet allograft rejection, and combination with starch-conjugated deferoxamin promotes islet engraftment in the preclinical pig model. Transplant. Proc. (2001) 33:509.
   PubMed Web of Science ®Google Scholar
• BRADLEY B, PROWSE SJ, BAULING P, LAFFERTY KJ: Desferrioxamine treatment prevents chronic islet allograft damage. Diabetes (1986) 35:550-555.
   PubMed Web of Science ®Google Scholar
• SANDBERG JO, EIZIRIK DL, SANDLER S, TRACEY DE, ANDERSSON A: Treatment with an iterleukin-1 receptor antagonist protein prolongs mouse islet allograft survival. Diabetes (1993) 42:1845-1851.
   PubMed Web of Science ®Google Scholar
• FAUST A, ROTHE H, SCHADE U, LAMPETER E, KOLB H: Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. Transplantation (1996) 62:648-652.
   PubMed Web of Science ®Google Scholar
• RABINOVITCH A, SUAREZ WL, POWER RF: Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice. J. Lab. Clin. Med. (1993) 121:603-607.
   PubMedGoogle Scholar
• SHAPIRO AM, HAO E, RAJOTTE RV, KNETEMAN NM: Impact of Lazaroid U74006F on ischemia and reperfusion injury of islets after transplantation in rat. Transplant. Proc. (1996) 28:85-86.
   PubMed Web of Science ®Google Scholar
• ARITA S, SAUL J, JOH S et al.: Islet protective effect of pravastatin from nonspecific inflammation in mouse pancreatic islet isografts. Transplant. Proc. (1996) 28:924.
   PubMed Web of Science ®Google Scholar
• ARITA S, NAGAI T, OCHIAI M et al.: Prevention of primary nonfunction of canine islet autografts by treatment with pravastatin. Transplantation (2002) 73:7-12.
   PubMed Web of Science ®Google Scholar
• BLEICH D, CHEN S, BURSTEN SL, NADLER JR: Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta induced dysfunction in cultured rat islets. Endocrinology (1996) 137:4871-4877.
   PubMed Web of Science ®Google Scholar
• BOTTINO R, FERNANDEZ LA, RICORDI C et al.: Transplantation of allogeneic islets of Langerhans in the rat liver – effects of macrophage depletion on graft survival and microenvironment activation. Diabetes (1998) 47:316-323.
   PubMed Web of Science ®Google Scholar
• BROWN M, BRAUN M, MERCADO P, CICALESE L, BENEDETTI E, RASTELLINI C: Pyruvate improves pancreatic islet engraftment and functionality. Transplant. Proc. (2001) 33:3523.
   PubMed Web of Science ®Google Scholar
• BOTTINO R, BALAMURUGAN AN, BERTERA S, PIETROPAOLO M, TRUCCO M, PIGANELLI JD: Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes (2002) 51:2561-2567.
   PubMed Web of Science ®Google Scholar
• RAO P, MAEDA H, SASAGURI S: Protective effect of a radical scavenger, MCI-186 on islet cell damages induced by oxidative stress. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-089.
   Google Scholar
• UNGER RH, GRUNDY S: Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia (1985) 28:119-121.
   PubMed Web of Science ®Google Scholar
• SANDLER S, JANSSON L: Blood flow measurements in autotransplanted pancreatic islets of the rat. Impairment of the blood perfusion of the graft during hyperglycemia. J. Clin. Invest. (1987) 80:17-21.
   PubMed Web of Science ®Google Scholar
• BRUNICARDI FC, STAGNER J, BONNER-WEIR S et al.: Microcirculation of the islets of Langerhans. Diabetes (1996) 45:385-392.
   Google Scholar
• JANSSON L: The regulation of pancreatic islet blood flow. Diab. Metab. Rev. (1994) 10:407-416.
   PubMed Web of Science ®Google Scholar
• JANSSON L, CARLSSON P: Graft vascular function after transplantation of pancreatic islets. Diabetologia (2002) 45:749-763.
   PubMed Web of Science ®Google Scholar
• HAYEK A, LOPEZ AD, BEATTIE GM: Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 50:931-933.
   PubMed Web of Science ®Google Scholar
• STAGNER JI, SAMOLS E: Induction of angiogenesis by growth factors: relevance to pancreatic islet transplantation. EXS (1992) 61:381-385.
   PubMedGoogle Scholar
• STAGNER JI, SAMOLS E: The induction of capillary bed development by endothelial growth factor before islet transplantation may prevent islet ischemia. Transplant. Proc. (1990) 22:824-828.
   PubMed Web of Science ®Google Scholar
• TRIVEDI N, STEIL GM, GOLTON CK, BONNER-WEIR S, WEIR GC: Improved vascularization of planar membrane diffusion devices following continuous infusion of vascular endothelial growth factor. Cell Transplant. (2000) 9:115-124.
   PubMed Web of Science ®Google Scholar
• LAI Y, SCHNEIDER D, KIDSZUN A et al.: Vascular endothelial growth factor increases functional beta-cell mass by improvement of angiogenesis of isolated human and murine Pancreatic Islets. Transplantation (2005) 79:1530-1536.
   PubMed Web of Science ®Google Scholar
• JOHANSSON M, JANSSON L, CARLSSON P: Prolactin pretreatment improves islet transplantation outcome. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-104.
   Google Scholar
• MATTSSOON G: The endothelial cells in islets of Langerhans. Ups. J. Med. Sci. (2005) 110:1-15.
   PubMed Web of Science ®Google Scholar
• ROSENBERG L, WANG R, PARASKEVAS S, MAYSINGER D: Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery (1999) 126:393-398.
   PubMed Web of Science ®Google Scholar
• PARASKEVAS S, MAYSINGER D, WANG R, DUGUID TP, ROSENBERG L: Cell loss in isolated human islets occurs by apoptosis. Pancreas (2000) 20:270-276.
   PubMed Web of Science ®Google Scholar
• CATTAN P, BERNEY T, SCHENA S et al.: Early assessment of apoptosis in isolated islets of Langerhans. Transplantation (2001) 71:857-862.
   PubMed Web of Science ®Google Scholar
• THOMAS D, YANG H, BOFFA D et al.: Proapoptotic bax is hyperexpressed in isolated human islets compared with antiapoptotic bcl-2. Transplantation (2002) 74:1489-1496.
   PubMed Web of Science ®Google Scholar
• NAKANO M, YASUNAMI Y, MAKI T et al.: Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts. Transplantation (2000) 69:214-221.
   PubMed Web of Science ®Google Scholar
• GARCIA-OCANA A, TAKAE KK, SYED MA, PHILBRICK WM, VASAVADA RC, STEWART AF: Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J. Biol. Chem. (2000) 275:1226-1232.
   PubMed Web of Science ®Google Scholar
• GARCIA-OCANA A, VASAVADA RC, CEBRIAN A et al.: Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcome in mice. Diabetes (2001) 50:2752-2762.
   PubMed Web of Science ®Google Scholar
• GIANNOUKAKIS N, MI Z, RUDERT WA, GAMBOTTO A, TRUCCO M, ROBBINS P: Prevention of beta cell dysfunction and apoptosis activation in human islets by adnoviral gene transfer of the insulin-like growth factor I. Gene Ther. (2000) 7:2015-2022.
   PubMed Web of Science ®Google Scholar
• YE J, LAYCHOCK G: A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1 beta. Endocrinology (1998) 139:4155-4163.
   PubMed Web of Science ®Google Scholar
• PILEGGI A, MOLANO RD, BERNEY T et al.: Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes (2001) 50:1983-1991.
   PubMed Web of Science ®Google Scholar
• TOBIASCH E, GUNTHER L, BACH FH: Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J. Invest. Med. (2001) 49:566-571.
   PubMed Web of Science ®Google Scholar
• PILEGGI A, MOLANO RD, BERNEY T et al.: Prolonged allogeneic islet graft survival by protoporphyrins. Cell Transplant. (2005) 14:85-96.
   PubMed Web of Science ®Google Scholar
• FENJVES ES, OCHOA MS, GAY-RABINSTEIN C et al.: Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets. Transplantation (2004) 77:13-18.
   PubMed Web of Science ®Google Scholar
• RIACHY R, VANDEWALLE B, KERR CONTE J et al.: 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. Endocrinology (2002) 143:4809-4819.
   PubMed Web of Science ®Google Scholar
• ZHANG G, MATSUMOTO S, HYON SH, QUALLEY S, REEMS J: Polyphenol, an extract of green tea, increases culture recovery rates of islets isolated from non-human primate pancreata and marginal grade human pancreata. Cell Transplant. (2004) 13:145-152.
   PubMed Web of Science ®Google Scholar
• NAKANO M, MATSUMOTO I, SAWADA T et al.: Caspase-3 inhibitor prevents apoptosis of human islets immediately after isolation and improves islet graft function. Pancreas (2004) 29:104-109.
   PubMed Web of Science ®Google Scholar
• NOGUCHI H, NAKAI Y, MATSUMOTO S et al.: Cell permeable peptide JNK inhibitor prevents islet apoptosis immediately after isolation and improves islet graft function. Am. J. Transplant. (2005) 5:1848-1855.
   PubMed Web of Science ®Google Scholar
• HUI H, DOTTA F, DI MARIO U, PERFETTI R: Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J. Cell. Physiol. (2004) 200:177-200.
   PubMed Web of Science ®Google Scholar
• ROBERTSON P: Islet transplantation as a treatment for diabetes- A work in progress. N. Engl. J. Med. (2004) 350:694-705.
   PubMed Web of Science ®Google Scholar
• STREET CN, LAKEY JR, SHAPIRO AM et al.: Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes (2004) 53:3107-3114.
   PubMed Web of Science ®Google Scholar
• ISHIZUKA J, GUGLIUZZA KK, WASSMUTH Z et al.: Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation (1993) 56:1486-1490.
   PubMed Web of Science ®Google Scholar
• PATY BW, HARMON JS, MARSH CL, ROBERTSON RP: Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation (2002) 73:353-357.
   PubMed Web of Science ®Google Scholar
• FROUD T, PONTE G, PILEGGI A et al.: Use of mycophenolate mofetil in islet transplant: University of Miami experience. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-098.
   Google Scholar
• FU F, HU S, DELEO J et al.: Long-term islet graft survival in streptozotosin and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720. Transplantation (2002) 73:1425-1430.
   PubMed Web of Science ®Google Scholar
• WIJKSTROM M, KENYON NS, KIRCHHOF N et al.: Islet allograft survival in nonhuman primates immunosuppressed with basilisimab, RAD, and FTY 720. Transplantation (2004) 77:827-835.
   PubMed Web of Science ®Google Scholar
• ADAMS AB, SHIRASUGI N, DURHAM MM et al.: Calcineurin inhibitor-free CD28 blockage-based protocol protects allogeneic islets in nonhuman primates. Diabetes (2002) 51:265-270.
   PubMed Web of Science ®Google Scholar
• ADAMS AB, SHIRASUGI N, JONES TR et al.: Development of a chimeric anti-CD 40 monoclonal antibody that synergies with LEA29Y to prolong islet allograft survival. J. Immunol. (2005) 174:542-550.
   PubMed Web of Science ®Google Scholar
• HEROLAD KC, HAGOPIAN W, ECKHOFF DE et al.: Anti-CD3 monoclonal antibody in new-onset Type 1 diabetes mellitus. N. Engl. J. Med. (2002) 346:1692-1698.
   PubMed Web of Science ®Google Scholar
• KENYON NS, FERNANDEZ LA, LEHMANN R et al.: Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes (1999) 48:1473-1481.
   PubMed Web of Science ®Google Scholar
• LARSEN CP, PEARSON TC: The CD40 pathway in allograft rejection, acceptance and tolerance. Curr. Opin. Immunol. (1997) 9:641-647.
   PubMed Web of Science ®Google Scholar
• KLEIN D, BARBE-TUANA F, PUGLIESE A et al.: A functional CD40 receptor is expressed in pancreatic beta cells. Diabetologia (2005) 48:268-276.
   PubMed Web of Science ®Google Scholar
• BRINKMAN V, PINSCHEWER D, CHIBA K, FENG L: FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol. Sci. (2000) 21:49-52.
   PubMed Web of Science ®Google Scholar
• DRAGUN D, BOHLER T, NIEMINEN-KELHA M et al.: FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury. Kidney Int. (2004) 65:1076-1083.
   PubMed Web of Science ®Google Scholar
• ANSELMO DM, AMERSI FF, SHEN XD et al.: FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-cell infiltration. Am. J. Transplant. (2002) 2:843-849.
   PubMed Web of Science ®Google Scholar
• TRONSCOSO P, STEPKOWSKI SM, WANG ME et al.: Prophylaxis of acute renal allograft rejection using FTY720 in combination subtherapeutic doses of cyclosporine. Transplantation (1999) 67:145-151.
   PubMed Web of Science ®Google Scholar
• SCHUURMAN H, MENNINGER K, AUDET M et al.: Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or combination with cyclosporine or RAD. Transplantation (2002) 74:951-960.
   PubMed Web of Science ®Google Scholar
• FERGUSON R: FTY 720 immunomodulation: Optimism for improved transplantationregimens. Transplant. Proc. (2004) 36(Suppl.):549S-553S.
   PubMed Web of Science ®Google Scholar
• HELIO TS, GEORGES M, BARRY K et al.: FTY720, a novel immunomodulator: Efficacy and safety results from the first Phase IIA study in de novo renal transplantation. Transplantation (2005) 79:1553-1560.
   PubMed Web of Science ®Google Scholar
• LINDGREN M, HALLBRINK M, PROCHIANTZ A, LANGEL U: Cell-penetrating peptides. Trends Pharmacol. Sci. (2000) 21:99-103.
   PubMed Web of Science ®Google Scholar
• SCHWARZE SR, DOWDY SF: In vivo protein transduction: intracellular biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. (2000) 21:45-48.
   PubMed Web of Science ®Google Scholar
• NOGUCHI H, MASTUSHITA M, OKITSU T et al.: A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat. Med. (2004) 10:305-309.
   PubMed Web of Science ®Google Scholar
• CONTRERAS JL, ECKHOFF DE, CARTNER S et al.: Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients. Transplantation (1999) 68:215-219.
   PubMed Web of Science ®Google Scholar
• KENYON NS, CHATZIPETROU M, MASETTI M et al.: Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc. Natl. Acad. Sci. USA (1999) 96:8132-8137.
   PubMed Web of Science ®Google Scholar
• THOMAS JM, CONTRERAS JL, SMYTH CA et al.: Successful reversal of streptozotocin-induced diabetes with stable allogeneic islet function in a preclinical model of Type 1 diabetes. Diabetes (2001) 50:1227-1236.
   PubMed Web of Science ®Google Scholar
• THOMAS JM, HUBBARD WJ, SOOUDI SK, THOMAS FT: STEALTH matters: a novel paradigm of durable primate allograft tolerance. Immunol. Rev. (2001) 183:223-233.
   PubMed Web of Science ®Google Scholar
• FONTES P, PAO AS, DEMETRIS AJ et al.: Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 344:151-155.
   PubMed Web of Science ®Google Scholar
• RASTELLINI C, SHAPIRO R, CORRY R, FUNG JJ, STARZL TE, RAO AS: An attempt to reserve diabetes by delayed islet cell transplantation in humans. Transplant. Proc. (1997) 29:2238-2239.
   PubMed Web of Science ®Google Scholar
• FARNEY AC, NAJARIAN JS, NAKHLEH RE et al.: Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis. Surgery (1991) 119:427-437.
   Google Scholar
• ROBERTSON RP, LANZ KJ, SUTHERLAND DE et al.: Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation (2002) 73:736-741.
   PubMed Web of Science ®Google Scholar
• DOR Y, BROWN J, MARTINEZ OI, MELTON DA: Adult pancreatic beta-cell are formed by self-duplication rather than stem-cell differentiation. Nature (2004) 429:41-46.
   PubMed Web of Science ®Google Scholar
• THORENS B, PORRET A, BUHLER L, DENG SP, MOREL P, WIDMANN C: Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes (1993) 42:1678-1682.
   PubMed Web of Science ®Google Scholar
• ZHOU J, WANG X, PINEYRO MA, EGAN JM: Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes (1999) 48:2358-2366.
   PubMed Web of Science ®Google Scholar
• STOFFERS DA, KIEFFER TJ, HUSSAIN MA et al.: Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein PDX-1 and increase islet size in mouse pancreas. Diabetes (2000) 49:741-748.
   PubMed Web of Science ®Google Scholar
• GEDULIN BR, NIKOULINA SE, SMITH PA et al.: Exenatide (exendin-4) improves insulin sensitivity and beta-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight. Endocrinology (2005) 146:2069-2076.
   PubMed Web of Science ®Google Scholar
• LI L, EL-KHOLY W, RHODES C, BRUBAKER PL: Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia (2005) 48:1339-1349.
   PubMed Web of Science ®Google Scholar
• OTONKOSKI T, CIRULLI V, BEATTIE M et al.: A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth. Endocrinology (1996) 271:1200-1208.
   Google Scholar
• RAFAELOFF R, PITTENGER GL, BARLOW SW et al.: Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J. Clin. Invest. (1997) 99:2100-2109.
   PubMed Web of Science ®Google Scholar
• TAM J, ROSENBERG L, MAYSINGER D: INGAP peptide improves nerve function and enhances regeneration in streptozotocin-induced diabetic C57BL/6 mice. FASEB J. (2004) 18:1767-1769.
   PubMed Web of Science ®Google Scholar
• BENNET W, BJORKLAND A, SUNDBERG B et al.: A comparison of fetal and adult porcine islets with regard to Gal alpha (1,3)Gal expression and the role of human immunoglobulins and complement in islet cell cytotoxicity. Transplantation (2000) 69:1711-1717.
   PubMed Web of Science ®Google Scholar
• RAYAT GR, RAJOTTE RV, HERING BJ, BINETTE TM, KORBUTT GS: In vitro and in vivo expression of Galalpha-(1,3)Gal on porcine islet cells is age dependent. J. Endocrinol. (2003) 177:127-135.
   PubMed Web of Science ®Google Scholar
• WIJKSTROM M, KIRCHHOF N, PILON KJ et al.: Xenogeneic pig islets escape rejection in immunosuppressed primates but fail to sustain normoglycemia. Am. J. Transplant. (2001) 1:153.
   Google Scholar
• WHITE DJG, VALDES R, DORANTES L et al.: Co-transplantation of porcine islets with Sertoli cells in Type 1 diabetic patients produces atypical humoral immune responses as assessed by elicited anti-pig antibodies. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) PS-100.
   Google Scholar
• ELLIOTT RB, ESCOBAR L, TAN PL, VASCONCELLOS AV, EMERICH DF, THANOS C: Long term survival of alginate encapsulated piglet islets in a patient with Type 1 diabetes. Abstract Book of 10th World Congress of International Pancreas and Islet Transplant Association. Geneva, Switzerland (2005) OP-054.
   Google Scholar
• YONEKAWA Y, MATSUMOTO S, OKITSU T et al.: Effective islet isolation method with extremely high islet yields from adult pigs. Cell Transplant. (2006) (In Press).
   Google Scholar
• HENEINE W, TIBELL A, SWITZER WM et al.: No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet (1998) 352:695-699.
   PubMed Web of Science ®Google Scholar
• VAN DER LAAN LJ, LOCKEY C, GRIFFETH BC et al.: Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature (2000) 407:90-94.
   PubMed Web of Science ®Google Scholar
• SWITZER WM, MICHLER RE, SHANMUGAM V et al.: Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation (2001) 71:959-965.
   PubMed Web of Science ®Google Scholar
• CLEMENCEAU B, JEGOU D, MARTIGNAT L, SAI P: Long-term follow-up failed to detect in vitro transmission of full-length porcine endogenous retroviruses from specific pathogen-free pig islets to human cells. Diabetologia (2001) 44:2044-2055.
   PubMed Web of Science ®Google Scholar
• GOTO M, MAEDA A, ELFMAN L et al.: No transmission of porcine endogenous retrovirus after transplantation of adult porcine islets into diabetic nude mice and immunosuppressed rats. Xenotransplantation (2004) 11:340-346.
   PubMed Web of Science ®Google Scholar
• SORIA B: In-vitro differentiation of pancreatic beta-cells. Differentiation (2001) 68:205-219.
   PubMed Web of Science ®Google Scholar
• SORIA B, SKOUDY A, MARTIN F: From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia (2001) 44:407-415.
   PubMed Web of Science ®Google Scholar
• RAJAGOPAL J, ANDERSON WJ, KUME S, MARTINEZ OI, MELTON DA: Insulin staining of ES cell progeny from insulin uptake. Science (2003) 299:363.
   PubMed Web of Science ®Google Scholar
• HANSSON M, TONNING A, FRANDSEN U et al.: Artifactual insulin release from differentiated embryonic stem cells. Diabetes (2004) 53:2603-2609.
   PubMed Web of Science ®Google Scholar
• BONNER-WEIR S, TANEJA M, WEIR GC et al.: In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA (2000) 97:7999-8004.
   PubMed Web of Science ®Google Scholar
• BONNER-WEIR S, TOSCHI E, INADA A et al.: The pancreatic ductal epithelium serves as a potential pool of progenitor cells. Pediatr. Diabetes (2004) 5(Suppl. 2):16-22.
   PubMed Web of Science ®Google Scholar
• JONSSON J, CARLSSON L, EDLUND T, EDLUND H: Insulin-promoter-factor 1 is required for pancreas development in mice. Nature (1994) 371:606-609.
   PubMed Web of Science ®Google Scholar
• OFFIELD MF, JETTON TL, LABOSKY PA et al.: PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development (1996) 122:983-995.
   PubMed Web of Science ®Google Scholar
• FERBER S, HALKIN A, COHEN H et al.: Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat. Med. (2000) 6:568-572.
   PubMed Web of Science ®Google Scholar
• NOGUCHI H, KANETO H, WEIR GC, BONNER-WEIR S: PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes (2003) 52:1732-1737.
   PubMed Web of Science ®Google Scholar
• NOGUCHI H, MATSUSHITA M, MATSUMOTO S, LU YF, MATSUI H, BONNER-WEIR S: Mechanism of PDX-1 protein transduction. Biochem. Biophys. Res. Commun. (2005) 332:68-74.
   PubMed Web of Science ®Google Scholar
• SMITH SB, WATADA H, GERMAN MS: Neurogenin3 activates the islet differentiation program while repressing its own expression. Mol. Endocrinol. (2004) 18:142-149.
   PubMed Web of Science ®Google Scholar
• NOGUCHI H, BONNER-WEIR S, WEI FY, MATSUSHITA M, MATSUMOTO S: BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes (2005) 54:2859-2866.
   PubMed Web of Science ®Google Scholar
• SOSA-PINEDA B: The gene Pax4 is an essential regulator of pancreatic beta-cell development. Mol. Cells (2004) 18:289-294.
   PubMed Web of Science ®Google Scholar
• HENSELEIT KD, NELSON SB, KUHLBRODT K, HENNINGS JC, ERICSON J, SANDER M: NKX6 transcription factor activity is required of alpha and beta cell development in the pancreas. Development (2005) 132:3139-3149.
   PubMed Web of Science ®Google Scholar
• DOMINGUEZ-BENDALA J, KLEIN D, RIBEIRO M et al.: TAT-mediated neurogenin 3 protein transduction stimulates pancreatic endocrine differentiation in vitro. Diabetes (2005) 54:720-726.
   PubMed Web of Science ®Google Scholar